These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 11814511)
1. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Spies JB; Coyne K; Guaou Guaou N; Boyle D; Skyrnarz-Murphy K; Gonzalves SM Obstet Gynecol; 2002 Feb; 99(2):290-300. PubMed ID: 11814511 [TBL] [Abstract][Full Text] [Related]
2. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire. Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082 [TBL] [Abstract][Full Text] [Related]
3. Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire: a Chinese translation and validation study. Yeung SY; Kwok JWK; Law SM; Chung JPW; Chan SSC Hong Kong Med J; 2019 Dec; 25(6):453-459. PubMed ID: 31796639 [TBL] [Abstract][Full Text] [Related]
4. Further validation of the uterine fibroid symptom and quality-of-life questionnaire. Coyne KS; Margolis MK; Bradley LD; Guido R; Maxwell GL; Spies JB Value Health; 2012 Jan; 15(1):135-42. PubMed ID: 22264981 [TBL] [Abstract][Full Text] [Related]
5. [Validation of the Chinese version of the uterine fibroid symptom and health-related quality of life]. Wang XQ; Zhu L; Xu T; Zhang L; Lyu T; Chen R Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):455-460. PubMed ID: 28797152 [No Abstract] [Full Text] [Related]
6. Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study. Keizer AL; van Kesteren PJM; Terwee C; de Lange ME; Hehenkamp WJK; Kok HS BMJ Open; 2021 Nov; 11(11):e052664. PubMed ID: 34815284 [TBL] [Abstract][Full Text] [Related]
7. Validation of the Spanish version of the Uterine Fibroid Symptom and Quality of Life (UFS-QoL) questionnaire in women with uterine myomatosis. Calaf J; Palacios S; Cristóbal I; Cañete ML; Monleón J; Fernández J; Hernández A; Vázquez F Med Clin (Barc); 2020 Mar; 154(6):207-213. PubMed ID: 31685223 [TBL] [Abstract][Full Text] [Related]
8. Translation and validation of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire for the Brazilian Portuguese language. Oliveira Brito LG; Malzone-Lott DA; Sandoval Fagundes MF; Magnani PS; Fernandes Arouca MA; Poli-Neto OB; Nogueira AA Sao Paulo Med J; 2017; 135(2):107-115. PubMed ID: 28301630 [TBL] [Abstract][Full Text] [Related]
9. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research. Coyne KS; Margolis MK; Murphy J; Spies J Value Health; 2012; 15(5):674-9. PubMed ID: 22867776 [TBL] [Abstract][Full Text] [Related]
10. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Harding G; Coyne KS; Thompson CL; Spies JB Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505 [TBL] [Abstract][Full Text] [Related]
11. Validity and Reliability of The Persian Version of Uterine Fibroid Symptom and Health-Related Quality of Life Questionnaire: A Psychometric Study. Najafiarab H; Keyvanfar A; Rahimi Mansour F; Didar H; Hooshmand Chayijan SH; Rajaei Firouzabadi SH; Hosseini MS; Bakhtiyari Z; Farzaneh F Int J Fertil Steril; 2023 Nov; 18(1):60-66. PubMed ID: 38041461 [TBL] [Abstract][Full Text] [Related]
12. Adaptability and clinical applicability of UFS-QoL in Chinese women with uterine fibroid. Xu W; Chen W; Chen J; Hu L; Su X; Nie Y; Shi Q BMC Womens Health; 2022 Sep; 22(1):372. PubMed ID: 36088381 [TBL] [Abstract][Full Text] [Related]
13. Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL). Coyne KS; Harrington A; Currie BM; Chen J; Gillard P; Spies JB J Patient Rep Outcomes; 2019 Aug; 3(1):57. PubMed ID: 31444600 [TBL] [Abstract][Full Text] [Related]
14. Impact of uterine fibroids on quality of life: a national cross-sectional survey. Hervé F; Katty A; Isabelle Q; Céline S Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225 [TBL] [Abstract][Full Text] [Related]
15. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950 [TBL] [Abstract][Full Text] [Related]
16. Uterine Fibroid Symptom - Quality of Life questionnaire translation and validation into Brazilian Portuguese. Silva RO; Gomes MT; Castro RA; Bonduki CE; Girão MJ Rev Bras Ginecol Obstet; 2016 Oct; 38(10):518-523. PubMed ID: 27832674 [No Abstract] [Full Text] [Related]
17. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test. Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268 [TBL] [Abstract][Full Text] [Related]
18. Further psychometric validation of the sexual life quality questionnaire for men with erectile dysfunction and their partners on a modified Spanish language version. Gutiérrez P; Hernández P; Sanz E; Cardeñosa O; Mas M J Sex Med; 2009 Oct; 6(10):2698-706. PubMed ID: 19453884 [TBL] [Abstract][Full Text] [Related]
19. Uterine Artery Embolization in Women with Symptomatic Cervical Leiomyomata: Efficacy and Safety. de Bruijn AM; Adriaansens SJH; Smink M; Venmans A; Hehenkamp WJK; Smeets AJ; Lopez A; Huirne JAF; Lohle PNM Cardiovasc Intervent Radiol; 2019 Mar; 42(3):371-380. PubMed ID: 30288591 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire. Ferner RE; Thomas M; Mercer G; Williams V; Leschziner GD; Afridi SK; Golding JF Health Qual Life Outcomes; 2017 Feb; 15(1):34. PubMed ID: 28193237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]